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Polymorphism  of mouse  kappa  chains  has  been  shown  to  be  associated  with 
chromosome 6 loci closely linked to the Ly-2,3 locus (1-5). Because the gene for the 
constant region of the kappa light chain, and at least certain genes for the variable 
region of the kappa light chain (V~)  x are now known to be located on chromosome 6 
(6,  7), the simplest interpretation of the kappa chain genetic differences is that they 
are a result of differences in the V~ genetic complex itself. Precise characterization of 
the genetic differences at both the protein and nucleic acid level could help define the 
number of light chains controlled by each V~ gene. For example, it is now apparent 
that many light chains may be produced from each V~ gene simply by combinatorial 
association with different J~ segments (8-11). In addition, each V~ gene may give rise 
to an as yet unknown number of somatic mutants, by normal mutation rates followed 
by clonal selection of useful variants in the course of immune responses (12). Although 
it  is  likely  that  both  of these  mechanisms  are  important  in  generating  antibody 
diversity, the extent to which they actually do occur could be gauged if one were able 
to  characterize  the  set  of gene  products  generated  by  a  given  V~  gene.  Genetic 
polymorphism involving differences of a  few V~ genes could provide an invaluable 
tool in this type of analysis. 
We have concentrated our attention on the structural differences controlled by the 
lgK-Ef2  locus  (5).  This locus controls differences in  normal  light  chain  isoelectrie 
focusing (IF) patterns, and it has been shown to be closely linked to two chromosome 
6 markers, Ly-3 and Hd (5). 
An  interesting aspect of the Ef2 marker was that  it appeared to involve discrete 
groups of light chains, as evidenced by the disappearance of certain bands from the 
normal light chain IF profiles of Ef2 ° strains, such as NZB mice, as compared with 
Ef2 a strains, such as BALB/c. The nature of the IF differences suggested that specific 
V~ genes might  either be absent  in  Ef2 n strains or, alternatively, not  expressed in 
serum immunoglobulin of these strains. To approach the question of the nature of the 
focusing bands seen in normal light chains and, in particular, to obtain information 
as to the identity of the polymorphic light chain bands, we screened a large number 
of BALB/c and NZB myelomas in search of light chains that cofocus with the major 
normal  light chain IF bands  affected by the IgK-Ef2 locus. This survey led to the 
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identification of 8 BALB/c myelomas (out of a total of 277 examined) that have light 
chains  indistinguishable  from  the  marker  light  chain  bands.  In  contrast,  no  light 
chains that cofocused precisely with the marker bands were identified  among a  total 
of 133 NZB myelomas (5). 
We  have  now obtained  partial  amino  acid  sequences  of 3  of the  BALB/c  light 
chains  in  question,  and  all  3  have  been  found  to  share  an  identical  amino  acid 
sequence over the first 30 residues.  This result provides strong support  for the notion 
that at least some of the discrete focusing bands (IF bands) observed in normal serum 
immunoglobulin light chains represent  light chains that belong to the same V-region 
group  (if not  subgroup).  It  also suggests  that  the  genetic  polymorphism  may be  a 
result of the absence of a  single V, gene or of a  cluster of closely related  V~ genes in 
Ef2 b strains  of mice.  The  surprisingly  high  frequency  of light  chains  of the  Ef2- 
related group among BALB/c myelomas suggests that it may represent one of a small 
number of V~ groups expressed at an elevated level. 
Materials  and Methods 
Mouse Myeloma Ascites Fluids.  Samples of BALB/c myeloma ascites fluids selected at random 
from the BALB/c myeloma collection were generously supplied by Dr. Michael Potter of the 
National Cancer Institute  (Bethesda,  Md.).  Samples of myeloma aseites  fluids of NZB mice 
were selected  only for being  good producers  and  were  otherwise  a  random  sample.  These 
samples were generously donated by Dr. Martin Weigert of the Institute for Cancer Research, 
Philadelphia, Pa. 
Production  of large  amounts  of immunoglobulin  from  the  BALB/c  tumors  TEPC-817, 
FLOPC-1, and TEPC  (CAL-20)-105 was undertaken  at the University of Sherbrooke (Sher- 
brooke, Canada) using pristane-primed BALB/cByJ mice or CAL-20 mice obtained from Dr. 
Judy Wax at Litton Bionetics, Kensington, Md. 
Isolation oflmmunoglobulins and Light Chains.  Ascites fluids were delipidated then diluted with 
an equal volume of phosphate-buffered saline (PBS).  A vol of 3.5 M  ammonium sulfate, pH 
7.3, equal to the diluted volume was then added, and precipitation was allowed to proceed for 
1 h at 0°C. The precipitate was redissolved in twice the original fluid volume of PBS, and the 
precipitation step was repeated. After three precipitations, the immunoglobulin was redissolved, 
dialyzed against  dilute ammonium bicarbonate, and lyophilized. Immunoglobulin was sub- 
jected to partial sulfityolysis  and heavy and light chains separated by gel filtration on Sephadex 
G100 (Pharmacia Fine Chemicals, Div. of Pharmacia, Inc., Piscataway, N. J.) in the presence 
of 0.1% sodium dodecyl sulfate as described (13). Light chains were then desalted on Sephadex 
G25 in ammonium carbonate and lyophilized. All light chain preparations were rechromato- 
graphed a second time on Sephadex G100. An alternative procedure, used for small preparations 
of light  chain,  was  partial  reduction  and  alkylati0n  with  iodoacetamide  followed  by  gel 
filtration on Ultragel ACA 34 in the presence of 3 M  guanidine HCI and 0.2 M  ammonium 
bicarbonate (14). 
Sequenator Procedures.  A  I-M quadrol program was used  (15) on a  modified Illitron model 
9001 sequenator (Illitron, Division of Illinois Tool Works Inc., Chicago, Ill.).  Program modifi- 
cations, such as solvent precipitation steps (16), were also incorporated. Conversion of thiazo- 
linone amino acid derivatives was done manually, using 25% trifluoroaeetic acid (TFA) at 60°C 
for 20 rain. After drying of the TFA, the entire residue was dissolved in 0.2 ml of methanol: 
acetonitrile  (50:50)  for injection  into the high-performance liquid chromatograph  (HPLC). 
Phenylthiohydantoin  (PTH)  amino acids were identified  by HPLC using a  Waters solvent 
programmer  and  delivery  system,  dual  wavelength  detector  (254  and  313  nm)  (Waters 
Associates,  Inc., Milford,  Mass.)  and a  Dupont 4.6-mm ×  25-cm Zorbax CN column  (E.  I. 
DuPont de Nemours & Co., Inc., Wilmington, Del.). Conditions ofelution were similar to those 
described by Johnson et al. (17). The gradient was from 0 to 55% solvent B (15% acetonitrile in 
methanol) using curv~ 2 over 20 rain. Solvent A consisted of 0.0167  M  sodium acetate buffer 
(pH 4.7). All solvents were millipore filtered.  Solvent A was also sterilized by autoclaving. In (2.  LAZURE, W.-T. HUM,  AND D.  M. GIBSON  557 
addition to HPLC, in certain instances,  residues were hydrolyzed and analyzed as free amino 
acids using a Technicon TSM- 1 amino acid analyzer (Technicon Instruments Corp., Tarrytown, 
N. Y.) (18). 
IF.  Procedures for purification of normal immunoglobulin, light chain isolation,  and IF of 
normal light chains have been described  (3, 5). For the analysis of myeloma ascites fluids,  1/~1 
of fluid was subjected to complete reduction and alkylation with [*4C]iodoacetamide (50 mCi/ 
mmol; Amersham Corp., Arlington  Heights, Ill.),  as  described.  The reduced  and alkylated 
material  was  directly  loaded  on  the  urea  formate  gel  for  chain  separation.  Because  no 
purification of the myeloma immunoglobulin was carried out, the myeloma light chain patterns 
were often contaminated by extraneous minor bands. In all cases the myeloma light chain 
bands were unequivocally identifiable as major unique bands. 
Results 
Differences Expressed in Normal BALB/c and NZB Light Chains.  Normal light chain 
IF spectra of NZB and BALB/c mice are illustrated in Fig. 1. Differences in the region 
of bands 54 and 63 are among the most prominent, although other distinct differences 
are also evident (e.g., bands 5 and 20). One of the eight BALB/c myeloma light chains 
corresponding to the bands  54/63  of the normal  pattern  is  also illustrated  (Fig.  1, 
position  d).  Fig.  2  shows  seven  of the  myeloma light  chains  cofocusing  with  the 
BALB/c  bands  63  and  54.  One of these  myelomas (TEPC-602)  displays a  second, 
probably unrelated, light-chain band. 
N-Terminal  Sequences of Ef2-related  Light  Chains.  Three of the  BALB/c  myeloma 
light  chains  corresponding  to the  Ef2  marker bands were each  sequenced  at  least 
twice over the N-terminal 40 residues. Unequivocal sequences were obtained for each 
of the  proteins  for the  first  30  positions  using  a  combination  of HPLC  and  back 
hydrolysis  procedures.  Sequence  data  obtained  for  the  light  chain  TEPC-817  is 
illustrated in Fig. 3. The sequences of the three proteins were indistinguishable  from 
each  other  and  were  identical  to  that  of the  light  chain  of MOPC-460,  a  well- 
characterized dinitrophenyl  (DNP)-binding myeloma protein (19). According to the 
classification of Potter (20), these sequences belong to the V~I group. A summary of 
sequences of light chains closely related to V, 1 is given in Table I. 
Closely Related  Light Chains Are Present in NZB Mice.  Examination of the available 
N-terminal sequence  data  for BALB/c  and  NZB  kappa chains  (21)  indicated  that 
two light  chains  with  a  sequence  identical  to that  of the Ef2  group in  the  first  23 
positions  have  also  been  found  in  NZB  myelomas  (Table  I).  This  was  somewhat 
surprising because it was expected that the group (in this case, V~I) representing the 
polymorphic bands would be reduced considerably, if not  absent,  in NZB, an IgK- 
Ef2 b strain. The two NZB light chains in question--namely, PC2205 and PC2567-- 
were clearly distinct  from the El2 group on IF however, which  indicated  that  they 
must differ structurally from the BALB/c proteins beyond position 23 in the variable 
region (Fig.  1 g and h). It is relevant to note in this context that members of the V~21 
group all share an identical sequence in the region of 1-23, but at least six subgroups 
(V~21A,  -B,  -C,  -D,  -E,  and  -F)  are  evident  when  the  entire  V-region  sequence  is 
considered (10). IF analysis also divides the V~21 group into at least six distinguishable 
subgroups, more in line with the results of total sequence analysis. 
Relationship  to MOPC-460 Light  Chain.  All  three  of the  Ef2  marker light  chains 
showed an amino acid sequence identical  to that of the light chain of the BALB/c 
myeloma protein  MOPC-460  over the  first  30  positions,  thus  indicating  that  these 
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Fro.  1.  IF  profiles  of normal  serum  immunoglobulin  light  chains  and  myeloma light  chains. 
Normal serum light chains of NZB mice are shown  in channels c and  f. Normal light chains of 
BALB/c mice are shown  in channels b and e. Light chains of the Ef2-related BALB/c myeloma 
FLOPC-1,  is in  channel  d.  Structurally related  myeloma light chains of MOPC-460  and  NZB 
myelomas PC2205  and PC2567  are in channels a, g, and h. Arrows indicate the major Ef2-related 
differences in the NZB and BALB/c light-chain profiles. The figure represents a l-wk autoradiogram 
of the dried gel. Arbitrary band numbers have been assigned simply to aid reference to the text and 
to Table I. 
MOPC-460  light chain showed that it was clearly distinct however, because it focused 
~3  charge  U  anodal  to  the  Ef2  light  chains  (Fig.  1 a).  Whether  or not  MOPC-460 
light chain may  be considered  to be a  somatic mutant  of the Ef2-related  group  is an 
interesting question and one that could better be answered when the complete amino 
acid sequences of these light chains  are available. C.  LAZURE,  W.-T.  HUM,  AND  D.  M.  GIBSON  559 
FIG.  2.  IF profiles of Ef2-rclated BALB/c mycloma light chains. Normal BALB/c light chain is 
shown in lanes a and f. Ef2-related myelomas TEPG-817, TEPG-(CAL-20)-10.5,  TEPC-821, TEPC 
(CAL-20)-119,  TEPG-602, FLOPC-1, and FLOPG-21  ((32) are shown in lanes b, c, d, e, g, h, and 
i. 
Discussion 
In  these studies,  we  believe we  have  identified one of the  important  V,  groups 
involved in  the Ef2 polymorphism previously described  (5).  Sequencing of the first 
three of the eight BALB/c myelomas found to possess light chains corresponding to 
the Ef2 marker bands  (63 and 54)  revealed an  identical sequence over the first 30 560  GENETIC CONTROL OF KAPPA LIGHT CHAINS 
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Recoveries of PTH amino acids in the automated degradation of the light-chain TEPC- 
residues.  The probability of selecting three proteins having sequence identity in the 
first 30 positions by chance is extremely low, so that the result, in itself, adds credibility 
to  interpretations  of light  chain  IF  data.  It  seems  likely  from  this  result  that  the 
majority  of the  remaining  five  myelomas identified  will  also  possess  the  same  N- 
terminal  sequence.  Complete  sequencing  of  these  light  chains  is  under  way  to 
determine whether they constitute a single subgroup or whether they represent several 
closely related subgroups. The frequency of occurrence of the Ef2-related light chains 
(8 out of a  total of 277 myelomas examined) suggests that the group must be one of 
a relatively small number of groups. According to the Poisson formula, if all samples 
fell into one of 100 equal groups, the expected proportion of groups represented 8 or 
more  times  would  be  0.0066.  If there  were  50  groups,  the  expected  proportion C.  LAZURE, W.-T. HUM, AND D. M. GIBSON 
TABLE I 
N-Terminal Sequences of Light Chains Related to the El2 Marker Bands  * 
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IF bands  Light chain  Strain  Reference 
I  5  l 0  15  2(~  25  30 
34.26  MOPC-460  D  VV  MT  QTPLS  LPVSI,  GI)OAS  ISC:R,%  SQ,~ILV  BALB/c  Barsmdet  al. llgl 
J5t~9  --  [  I __  BAI,B/c  Bacstad et al. (19) 
63, 54  TEPC-817  BAI,B/c  Tiffs x~ork 
63.54  PLOPC-I  Ig..'~LB/c  This work 
63, 54  TEPC (CAL+:20)-I05  BAI+B/c  This ++ork 
62.5, 52  2205  NZB  I,oh t't  +l[. (21) 
62, 49  2567  NZB  Loh ct al. (21) 
* BALB/c myelomas  corresponding  to El2 marker bands 54 and 63 include TEPC-817, FLOPC-I, TEPC (CAL- 
20)-105, TEPC-602, TEPC-821, TEPC (CAL-20)-119,  FLOPC-21 (G2),  and RAW-124. 
represented 8  or more times would  be 0.178,  a  more reasonable probability.  This 
calculation would therefore suggest that the number of groups of light chains similar 
to the El2 group would be closer to 50 than to  100. Whether or not the sequences 
represented in the myelomas are a valid sampling of the total repertoire is of crucial 
importance in considering extrapolation of these calculations to the total number of 
light-chain groups. This point has been raised by Loh et al.  (21)  in their analysis of 
the  sequences of randomly  selected BALB/c and  NZB  kappa  chains.  Our  results 
indicate that  the proportion of Ef2-related light  chains in normal serum  immuno- 
globulin  and  artificially reconstituted  mixtures of myeloma proteins  is  similar,  as 
judged by the relative intensities of the bands on autoradiograms of IF gels. 
In considering the implications of the present results for our interpretations of the 
genetically controlled  light-chain  polymorphism,  the  central  assumption  we  must 
make is that the V, group defined by the cofocusing myelomas is, in fact, the same V~ 
group that we observe in normal serum light chains (identifiedas bands 63 and 54). 
We feel this assumption is valid for the following reasons: First, the selection of three 
light  chains  identical  over  the  first  30  positions  simply  by  the  criterion  of  IF 
dramatically  demonstrates  the  validity  of the  method  as  a  means  of identifying 
sequence-related light chains.  There is no reason to doubt  that  the same degree of 
selectivity is also obtained when the method is applied to the normal light-chain pool 
and, therefore, that light chains in the normal pool showing close sequence relation- 
ships will focus together as a group or band. Secondly, the finding that three closely 
related light chains cofocus precisely with the normal  light-chain bands  54 and 63 
also indicates that a bona fide V~ sequence group corresponding to these bands does, 
in fact, exist among BALB/c myeloma immunoglobulins. It follows that if such light 
chains exist in normal serum immunoglobulin they will also eofocus with the marker 
bands 54 and 63. 
The fact that discrete groups of light chains are controlled by the IgK-Ef2 locus is 
more readily explained by proposing that  the polymorphism involves structural V~ 
genes rather than regulatory loci. Regulatory loci such as that  described for the  hi 
light-chain subgroup do, nevertheless, exist (22), and one could suppose that similar 
loci might control kappa subgroups as well. This would necessarily be more compli- 
cated for kappa chains because there may be on the order of 300 V~ subgroups (23), 
which would imply the existence of multiple regulatory loci. Other Ly-2,3-1inked V~ 
loci such  as lgK-Efl  (24), IgK-Pc (25), and  IgK-Trp  (26), each of which appears  to 
control  structurally  related  subsets  of kappa  chains,  could  also  be  supposed  to 562  GENETIC  CONTROL OF  KAPPA LIGHT CHAINS 
represent V~ regulatory loci. One weakness of the argument for regulatory loci is that 
it implies some functional significance for each control group of light chains. Because 
light chains of each V~ subgroup are believed to associate with a wide variety (if not 
all possible)  heavy chain variable region partners to give different functional combi- 
nations, the existence of a specific function for individual V~ genes is unlikely. If it is 
assumed that the polymorphism is a result of differences in content of V~ genes or in 
sequences adjacent to V, genes directly affecting their expression; the present results 
would suggest that mice carrying the IgK-Ef2 b allele have defective or missing genes 
corresponding to the V  region of TEPC-817,  FLOPC-1, TEPC  (CAL-20)-105,  etc. 
(V,1).  Because extensive gene duplication and deletion must have occurred during 
the evolution of immunoglobulin V regions (27-29), it would not be too surprising to 
find polymorphism of gene numbers within the inbred strains of mice (30). The fact 
that multiple differences in normal light-chain IF patterns are controlled by IgK-Ef2 
would suggest  that  several V~ subgroups  may be  involved.  Identification of other 
subgroups of light chains affected by IgK-Ef2 by further analysis of the BALB/c and 
NZB myeloma collections could be useful from the point of view of genetic mapping 
of the V, locus. One would expect that subgroups that were simultaneously deleted 
by unequal crossing over would be close together on the chromosome. Similar analysis 
could also be  made of the more extensive differences associated with the IgK-Efl 
polymorphism (3). 
The finding that one of the major groups of light chain controlled by IgK-Ef2 is 
closely related to the MOPC-460  light chain has implications in terms of the anti- 
DNP antibody response. Because it is known that MOPC-460 has a high affinity for 
DNP (31) it will be interesting to examine light chains produced in the DNP response 
in strains of mice differing with respect to lgK-Ef2.  We are currently engaged in these 
studies. It is of great interest to note that others have found that Ef2  b strains such as 
C58 are unable to produce anti-DNP antibodies carrying the MOPC-460  idiotype 
(32).  It seems  likely from this  result  that Ef2-controlled  light chains may well be 
involved in the anti-DNP immune response and, in particular, that they may be the 
subgroup required for expression of the MOPC-460 idiotype. 
It is clear that resolution of the question of whether the light-chain polymorphism 
involves regulatory or structural genes will require direct examination of the structural 
genes. The identification of a major structurally related set of light chains controlled 
by the lgK-Ef2 locus will greatly aid in this analysis. It should be noted though that 
sequences closely related to the polymorphic group are also found in IgK-Ef2 b strains 
(e.g., NZB), and this could complicate attempts to directly demonstrate the absence 
of given V, structural genes at the DNA level. 
Summary 
We previously demonstrated that loci closely linked to the Ly-3 locus control the 
expression of distinct sets  of light chains in normal mouse serum immunoglobulin. 
One of these loci, IgK-Ef2, was shown to control two major bands in normal light 
chain  isoelectric  focusing  (IF)  profiles.  Strains  possessing  the  marker  bands  were 
designated IgK-Ef2 a. Screening of myeloma proteins from the strains BALB/c (IgK- 
El2 ~) and NZB (IgK-Ef2 b) led to the identification of eight proteins in the BALB/c 
collection having light chains that cofocus precisely with the polymorphic IF bands 
observed  in  normal serum light chains.  Partial sequence analysis of 3 of the light C.  LAZURE,  W.-T. HUM, AND  D.  M. GIBSON  563 
chains has shown that they are all identical in the first 30 positions, which indicates 
that they constitute a single variable region of the kappa light chain (V~) group (V~I). 
The frequency of occurrence of the group within the BALB/c myeloma collection (8 
out of 277)  suggests that the number of such groups may be closer to 50 than to 100. 
The finding supports an interpretation  of the genetic polymorphism as being in part 
a  result of the absence of genes related to V~I in IgK-Ef2 b strains of mice. 
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